Global Cancer Diagnostics Market

Cancer Diagnostics Market Size, Share, Growth Analysis, By Application(Lung Cancer, Colorectal Cancer, Breast Cancer, Melanoma), By End User(Hospitals, Diagnostic Laboratories, Others), By Product(Instruments, Consumables), By Technology(IVD Testing, Imaging Technologies, Biopsies), By Region - Industry Forecast 2025-2032


Report ID: SQMIG35J2078 | Region: Global | Published Date: August, 2024
Pages: 157 | Tables: 149 | Figures: 78

Cancer Diagnostics Market Dynamics

Drivers

Rising Incidence of Cancer

  • Poor lifestyle choices and growing adoption of unhealthy habits have significantly increased the number of people suffering from cancer. This surge in incidence of cancer around the world is a key factor promoting cancer diagnostics demand.

Rising Awareness Regarding Cancer Diagnosis

Governments and public health organizations are continuously working on raising awareness regarding cancer symptoms and this is projected to promote the demand for cancer diagnostics in the future. As more and more people grow aware of cancer symptoms, the demand for early and better diagnostics also rises thereby promoting market growth.

Restraints

Limited Access

  • Underdeveloped and developing countries around the world are still working on developing their healthcare infrastructure. Healthcare institutions in these countries operate on a limited spending potential, which is why they cannot spend on advanced diagnostic devices thereby reducing access to novel diagnostic procedures.

False Positives

  • Novel diagnostic procedures which are not tested enough run the risk of generating false positives and cause anxiety among patients and medical professionals as well. This risk of false positives could slow down the adoption of advanced cancer diagnostics.   
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Cancer Diagnostics Market Size was valued at USD 112.3 Billion in 2022 and is expected to rise from USD 120.04 Billion in 2023 to USD 204.55 Billion by 2031, at a CAGR of 6.89% during the forecast period (2024–2031).

Developing cancer diagnostics that can detect cancer in early stages will be highly important for all companies operating in this market. Cancer diagnostics providers around the world are estimated to focus on research to maximize their business potential and stay competitive. Taking advantage of supportive government initiatives and awareness programs to maximize cancer diagnostics sales will also be a preferred strategy for all market players going forward. 'Abbott Laboratories (US)', 'Agilent Technologies (US)', 'Becton, Dickinson and Company (BD) (US)', 'bioMérieux SA (France)', 'Danaher Corporation (US)', 'Hoffmann-La Roche Ltd. (Switzerland)', 'GE Healthcare (US)', 'Hologic, Inc. (US)', 'Illumina, Inc. (US)', 'Koninklijke Philips N.V. (Netherlands)', 'Merck KGaA (Germany)', 'Myriad Genetics, Inc. (US)', 'QIAGEN N.V. (Netherlands)', 'Siemens Healthineers AG (Germany)', 'Sysmex Corporation (Japan)', 'Thermo Fisher Scientific Inc. (US)', 'Exact Sciences Corporation (US)', 'Guardant Health, Inc. (US)', 'Caris Life Sciences (US)', 'Foundation Medicine, Inc. (US)'

Poor lifestyle choices and growing adoption of unhealthy habits have significantly increased the number of people suffering from cancer. This surge in incidence of cancer around the world is a key factor promoting cancer diagnostics demand.

Use of AI for Diagnostics: Cancer diagnostics companies can focus on integrate artificial intelligence technology in their offerings to enhance their accuracy and efficiency going forward. Especially use of AI with diagnostic imaging is an area where cancer diagnostics companies can find multiple new business opportunities in the future.

North America is predicted to spearhead the demand for cancer diagnostics in the world. The presence of a robust healthcare infrastructure and rising healthcare expenditure are driving cancer diagnostics market growth in this region.  High investments in oncology R&D and favorable reimbursement policies are also estimated to help the dominance of this region. Canada and the United States are slated to be the most important markets in North America going forward.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cancer Diagnostics Market

Report ID: SQMIG35J2078

$5,300
BUY NOW GET FREE SAMPLE